Dernière étude sur le #Tocilizumab,
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 - PubMed
▻https://pubmed.ncbi.nlm.nih.gov/33085857
Résumé par les auteurs même :
Tocilizumab does not improve symptoms or prevent death in moderately ill hospitalized patients with #COVID-19
▻https://www.massgeneral.org/news/press-release/Tocilizumab-does-not-improve-symptoms-or-prevent-death-in-moderately-il
Key Takeaways
The drug tocilizumab does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19
Patients treated with tocilizumab were just as likely as those given placebo infusions to eventually require intubation or die over a four-week period
Conditions of patients who received the drug or the placebo improved or worsened at the same rate